Physician profile
Yuhe Hu
NPI 1588071450
$1,752.78
in general payments reported to CMS, 2019-2025
17 companies · $568 in 2025
The $568 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.25 · 2022: $320 · 2023: $197 · 2024: $614 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $367.33 | 2023-2025 | Evenity, Prolia, Prolia |
| Novo Nordisk INC | $342.59 | 2021-2025 | Rybelsus, Ozempic |
| Gilead Sciences, INC. | $294.28 | 2024-2025 | |
| Glaxosmithkline, LLC. | $126.47 | 2022-2023 | Shingrix, Arexvy |
| Biohaven Pharmaceutical Holding Company LTD. | $107.44 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $79.71 | 2025 | Zoryve |
| Abbvie INC. | $69.32 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $67.38 | 2025 | Purified Cortrophin Gel |
| Lilly USA, LLC | $61.70 | 2022-2025 | Mounjaro |
| Phathom Pharmaceuticals, INC. | $47.91 | 2024 | Voquezna |
| Exact Sciences Corporation | $39.70 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $37.64 | 2021-2022 | |
| Edwards Lifesciences Corporation | $27.30 | 2023 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $23.35 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.75 | 2024 | Caplyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.08 | 2025 | |
| Ibsa Pharma INC. | $17.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuhe Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.